tbuckley/cabot-search huggingface dataset:
FRI-403 Evaluation of a novel hepatitis B DNA test from fingerstick capillary blood at the point-of-care as a tool to enhance clinical management
Authors: Behzad Hajarizadeh, Jacob George, Miriam Levy, Ian Wong, Jess Howell, Gesalit Cabrera, Elise Tu, Marianne Martinello, Tanya Applegate, Gail Matthews
Journal: Journal of Hepatology (2024)
FRI-411-YI Proportions of indeterminate phase of patients with chronic hepatitis B virus infection according to different international guidelines
Authors: Shaoqiu Zhang, Chao Jiang, Jian Wang, Zhiyi Zhang, Fei Cao, Li Zhu, Ye Xiong, Tao Fan, Xiaomin Yan, Yuxin Chen, Chuanwu Zhu, Xingxiang Liu, Jie Li, Chao Wu, Rui Huang
Journal: Journal of Hepatology (2024)
WED-386 A double-blind, placebo-controlled, single-ascending dose phase I a study to evaluate the safety, tolerability, and pharmacokinetics of HT-101, an investigational small interfering ribonucleic acid targeting hepatitis B virus in Chinese healthy subjects
Authors: Jianxiong Zhang, Dong Wang, Shanzhong Zhang, Yanqin Ma, Lijuan Ding, Zhipeng Zhang, Hong Ma, Jidong Jia, Ruihua Dong
Journal: Journal of Hepatology (2024)
WED-413 10-year results under tenofovir disoproxil fumarate and entecavir in chronic hepatitis B; HBV clearance rare, disease outcomes good
Authors: Zülal İstemihan, Gamze Kemeç, Timurhan Cebeci, Okan Cetin, Sezen Genç Uluçeçen, Aynure Rüstemzade, Kanan Nuriyev, Bilger Çavuş, Asli Çifcibasi Örmeci, Filiz Akyuz, Kadir Demir, Fatih Beşışık, Sabahattin Kaymakoğlu
Journal: Journal of Hepatology (2024)
THU-397-YI Long-term histological fibrosis evolution following sustained virological response after hepatitis C-recurrence in livertransplanted patients
Authors: Tibo Lemmens, Cindy Serdjebi, Guillaume Henin, Selda Aydin, Pamela Baldin, Florine Chandes, Géraldine Dahlqvist
Journal: Journal of Hepatology (2024)
WED-361 Dosing with the Capsid Assembly Modulator ALG-000184 in Untreated HBeAg Negative CHB Subjects Results in Potent Antiviral Effects Including Suppression of HBV DNA/RNA and Declines in HBcrAg Levels
Authors: Kosh Agarwal, Edward J. Gane, Man-Fung Yuen, Christian Schwabe, Alina Jucov, Alexei Haceatrean, Min Wu, Kha Le, Maida Maderazo, Lawrence Blatt, Sushmita Chanda, Tse-I Lin, Matt McClure
Journal: Journal of Hepatology (2024)
WED-410 Sustained virological response after treatment with Bulevirtide in HDV patients. Data from the french multicenter real-life cohort
Authors: Victor de Lédinghen, Karine Lacombe, Stanislas Pol, Laurent Alric, Caroline Lascoux-Combe, Dulce Alfaiate, Marie-Noëlle Hilleret, Nathalie Ganne-Carrié, Jérôme Gournay, Veronique Loustaud-Ratti, Miroslava Subic-Levrero, Fatoumata Coulibaly, Estelle Le Pabic, Christelle Tual, Segolene Brichler, Fabien Zoulim
Journal: Journal of Hepatology (2024)
WED-375 VTP-300 immunotherapeutic, plus low dose PD-1 inhibitor, nivolumab, continues to show meaningful, sustained reductions in HBsAg levels
Authors: Dereck Tait, Louise Bussey, Radka Kolenovska, Matt Downs, Katie Anderson, Antonella Vardeu, Man-Fung Yuen, Wan-Long Chuang, Chun-Jen Liu, Apinya Leerapun, Pisit Tangkijvanich
Journal: Journal of Hepatology (2024)
TOP-417 Machine learning can improve prediction of hepatitis B surface antigen seroclearance: A large multicentre cohort study in the United Kingdom
Authors: Tingyan Wang, Jakub Jaworski, Ben Glampson, Dimitri Papadimitriou, Luca Mercuri, Christopher R. Jones, Stacy Todd, Karl McIntyre, Andrew Frankland, Hizni Salih, Gail Roadknight, Stephanie Little, Theresa Noble, Kinga A. Várnai, Cori Campbell, Cai Davis, Ashley I. Heinson, Michael George, Florina Borca, Louise English, Luis Romão, David Ramlakhan, William Frisby, John Taylor, Kerrie Woods, Jim Davies, Eleni Nastouli, Salim I. Khakoo, Alexander J. Stockdale, Nicholas Easom, Graham S. Cooke, William Gelson, Philippa C. Matthews, Eleanor Barnes
Journal: Journal of Hepatology (2024)
WED-404 Comparable outcomes between Besifovir and other antiviral therapies in hepatocellular carcinoma development among patients with chronic hepatitis B
Authors: Jae Seung Lee, Sung Won Lee, Sang Gyune Kim, Yeon Seok Seo, Su Jong Yu, Hyung Joon Yim, Hye Won Lee, Mi Na Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim
Journal: Journal of Hepatology (2024)
FRI-367 Prediction of hepatocellular carcinoma risk and liver-related events in chronic hepatitis D, an international retrospective cohort study (RIDE)
Authors: Lesley A. Patmore, Michelle Spaan, Kosh Agarwal, Ozgur Koc, Hans Blokzijl, Samantha Brouwer, Hanneke van Soest, Astrid van Hulzen, Harry L.A. Janssen, Jolanda Lammers, Louis Jansen, Mark Claassen, Robert A. de Man, R. Bart Takkenberg, Remco van Dijk, Dirk Posthouwer, Jurriën Reijnders, Ivana Carey, Milan J. Sonneveld
Journal: Journal of Hepatology (2024)
FRI-387 Similarly low risk of hepatocellular carcinoma and cirrhotic complications in patients in the HBeAg-negative indeterminate phase compared with chronic infection
Authors: Vicki Wing-Ki Hui, Terry Cheuk-Fung Yip, Yee-Kit Tse, Jimmy Che-To Lai, Henry L.Y. Chan, VincentWai-Sun Wong, Grace Lai-Hung Wong
Journal: Journal of Hepatology (2024)
FRI-362-YI Hepatitis B surface antigen (HBsAg) seroclearance following discontinuation of nucleos (t)ide analogues (NA) treatment has comparable durability to HBsAg seroclearance achieved during NA therapy
Authors: Terry Cheuk-Fung Yip, Mandy Sze-Man Lai, Jimmy Che-To Lai, Yee-Kit Tse, Henry L.Y. Chan, Vincent Wai-Sun Wong, Grace Lai-HungWong
Journal: Journal of Hepatology (2024)
SAT-404 The Lipidome in phenotyping hepatitis B infection (‘LiPHe-B’): preliminary results from our pilot study
Authors: Marion Delphin, Susana Palma-Duran, Mariana Silva dos Santos, Emily Martyn, Elizabeth Waddilove, Emma Wall, Tongai Gibson Maponga, Jacqueline Martin, Catherine De Lara, Paul Klenerman, Eleanor Barnes, James Macrae, Philippa C Matthews
Journal: Journal of Hepatology (2024)
SAT-389 HBV and HBsAg strongly reshape the phenotype, function and metabolism of DCs according to patients’ clinical stage
Authors: Lucile Dumolard, Gerster Théophile, Florent Chuffart, Thomas Decaens, Marie-Noëlle Hilleret, Sylvie Larrat, Philippe Saas, Evelyne Jouvin-Marche, David Durantel, Patrice N Marche, Zuzana Macek Jilkova, Caroline Aspord
Journal: Journal of Hepatology (2024)
FRI-432 The concentration of HDV-RNA correlates with the probability of developing clinical events in patients with chronic hepatitis D
Authors: Adriana Palom, Sergio Rodriguez-Tajes, Ariadna Bono, Antonio Madejón, Ariadna Rando-Segura, Sabela Lens, Marina Berenguer, Francisco Javier Garcia-Samaniego, Juan Carlos Ruiz-Cobo, Ângela Carvalho-Gomes, Elena Vargas-Accarino, Mar Riveiro Barciela, Rafael Esteban, Maria Buti
Journal: Journal of Hepatology (2024)
THU-404 Impact of hepatitis C treatment on mortality among liver cancer patients in Georgia-2015–2022
Authors: Anna Khoperia, Maia Butsashvili, Shaun Shadaker, Susan Gawel, Sophia Surguladze, Nazibrola Chitadze, Konstantine Kazanjan, Vladimer Getia, Lasha Gulbiani, Geoff Beckett, Alan Landay, Maia Tsereteli, Maia Alkhazashvili, Amiran Gamkrelidze, Francisco Averhoff
Journal: Journal of Hepatology (2024)
WED-365 Extended treatment of HBeAg+ CHB subjects with the Capsid assembly modulator ALG-000184 with or without Entecavir is associated with reductions in viral markers and favorable anti-HBeAb trends
Authors: Man-Fung Yuen, Edward J. Gane, Kosh Agarwal, Junqi Niu, Hong Ren, Yanhua Ding, Xieer Liang, Xian Yu, Jia Xu, Alina Jucov, Alexei Haceatrean, Min Wu, Kha Le, Maida Maderazo, Lawrence Blatt, Sushmita Chanda, Tse-I Lin, Matt McClure, Jinlin Hou
Journal: Journal of Hepatology (2024)
TOP-401-YI Improvement of liver stiffness during nucleo (s)tide analogue treatment in patients with chronic hepatitis B and advanced fibrosis is not associated with a reduction in hepatocellular carcinoma risk
Authors: Lesley A. Patmore, Yan Liang, Mai Kilany, Arno Furquim d'Almeida, Vincent Wai-Sun Wong, Thomas Vanwolleghem, Pieter Honkoop, Hans Blokzijl, Ozgur Koc, Harry L.A. Janssen, Matthijs Kramer, Joep de Bruijne, A. Kaewdech, Robert A. de Man, R. Bart Takkenberg, Grace Lai-Hung Wong, Jordan J. Feld, Milan J. Sonneveld
Journal: Journal of Hepatology (2024)
FRI-412 Quantification of plasma hdv rna in untreated and bulevirtidetreated patients with chd: a comparison between robogene 2.0, eurobioplex and altostar
Authors: Maria Paola Anolli, Sara Uceda Renteria, Elisabetta Degasperi, Floriana Facchetti, Dana Sambarino, Marta Borghi, Riccardo Perbellini, Roberta Soffredini, Sara Monico, Ferruccio Ceriotti, Pietro Lampertico
Journal: Journal of Hepatology (2024)
FRI-434 High levels of anti-HBc are associated with higher rates of immune control after 48 weeks of treatment with PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B
Authors: Maria Pfefferkorn, Simon Handrick, Melanie Maier, Cynthia Wat, Thomas Berg, Florian van Bommel
Journal: Journal of Hepatology (2024)
FRI-418 10-year clinical outcomes in chronic hepatitis B patients treated with tenofovir in The Gambia, West Africa
Authors: Erwan Vo Quang, Gibril Ndow, Sulayman Bah, Rohey Bangura, Lamin Bojang, Bakary Dibba, Sainabou Drammeh, Alhagie Touray, Kitabu Jammeh, Isabelle Chemin, Amie Ceesay, Gavin Cloherty, Umberto D'Alessandro, Mark R. Thursz, Yusuke Shimakawa, Maud Lemoine
Journal: Journal of Hepatology (2024)
FRI-442 Disease progression and persistent alanine aminotransferase elevation in HCV/HIV persons after DAA-related eradication: role of HBV and HDV co-infections
Authors: Roberto Rossotti, Alessandro Tavelli, Vincenzo Malagnino, Valentina Svicher, Eugenia Quiros-Roldan, Alessandra Bandera, Francesco Maria Fusco, Marco Rivano Capparuccia, Giovanni Battista Gaeta, Valentina Mazzotta, Massimo Puoti, Antonella D'Arminio Monforte
Journal: Journal of Hepatology (2024)
WED-390 Efficacy and safety of tenofovir alafenamide fumarate in preventing HBV vertical transmission in high maternal viral load: a multi-centre, prospective cohort study
Authors: Xingfei Pan, Fang He, Xujing Liang, Jiangxia Qin, Yanqiu Li, Xueting Ou, Zicong Liang, Panpan Zhai, Liyang Zhou, Xiaoping Tang
Journal: Journal of Hepatology (2024)
FRI-382 The predictive value of serum HBV RNA level in chronic hepatitis B patients treated with nucleos (t)ide analogues
Authors: Yuxuan Song, Yandi Xie, Xiaojing Zhang, Rongkuan Li, Sujun Zheng, Shuyun Zhang, Ping Li, Erhei Dai, Xuefei Duan, Juan Liu, Bo Feng, Fengmin Lu
Journal: Journal of Hepatology (2024)
WED-374 Safety, tolerability, and pharmacokinetics of BJT-778, a monoclonal antibody for treatment of chronic hepatitis B and chronic hepatitis D, following single ascending doses in healthy volunteers
Authors: Edward J. Gane, Christian Schwabe, Patrick Smith, Courtney Moc Willeford, Carole Moore, Roy Grecko, Keting Chu, Hassan Javanbakht, Nancy Shulman
Journal: Journal of Hepatology (2024)
THU-395 Is hepatitis C screening based on risk factors enough in primary care setting?
Authors: Elena Vargas-Accarino, Ariadna Rando-Segura, Ingrid Arcusa, Eva de Diego, Núria García, Elena Monserrat, Marta Selvi, Maria Asuncion Ubeda Pastor, Imma Valls, Carla Ventosa, Adriana Palom, Judit Romero-Vico, Juan Carlos Ruiz-Cobo, Mar Riveiro Barciela, Rafael Esteban, Maria Buti
Journal: Journal of Hepatology (2024)
WED-364 High-dimensional analysis of flow cytometry data reveals differences in post-treatment frequencies of naïve B cells, CD56dim natural killer cells, and terminally differentiated effector memory CD8+ T cells in responders versus nonresponders to bepirovirsen
Authors: Thea Hogan, Eduardo Gomez Castaneda, Esther Perez Garcia, Ruth Barnard, Avijit Ray, Melanie Paff, Dickens Theodore, Jennifer M. Singh
Journal: Journal of Hepatology (2024)
WED-414 Demographic, virological and clinical features of patients with chronic hepatitis delta treated with bulevirtide: a multicenter italian study (d-shield)
Authors: Maria Paola Anolli, Elisabetta Degasperi, Giampiero D'Offizi, Alessia Rianda, Alessandro Loglio, Mauro Viganò, Alessia Ciancio, Yulia Troshina, Maurizia Brunetto, Barbara Coco, Serena Zaltron, Pierluigi Toniutto, Letizia Marinaro, Andrea Gori, Alessandro Federico, Teresa Santantonio, Gabriella Verucchi, Filomena Morisco, Alessandra Mangia, Stella De Nicola, Monia Maracci, Antonietta Romano, Pietro Gatti, Rosa Zampino, Marcello Persico, Pietro Pozzoni, Adriano Pellicelli, Nicola Coppola, Francesca Pileri, Matteo Tonnini, Massimo Puoti, Pietro Lampertico
Journal: Journal of Hepatology (2024)
THU-387 Safety and efficacy of two pangenotypic direct acting antivirals (sofosbuvir/velpatasvir and glecaprevir/pibrentasvir) for the treatment of hepatitis C in children
Authors: Maria Pokorska-Śpiewak, Ewa Talarek, Anna Dobrzeniecka, Małgorzata Aniszewska, Magdalena Pluta, Magdalena Marczyńska
Journal: Journal of Hepatology (2024)
SAT-397 Transcriptomic analysis and high-throughput hepatitis B virus integration sequencing of HepaD38 cells
Authors: Cristina Musolino, Daniele Lombardo, Valeria Chines, Giuseppina Raffa, Domenico Giosa, Riccardo Aiese Cigliano, M'hommed Aguenoz, Giovanni Raimondo, Teresa Pollicino
Journal: Journal of Hepatology (2024)
WED-378 Association of baseline characteristics and plasma ALG-001075 to HBsAg responses in HBeAg+ CHB subjects following ALG-000184 ± ETV treatment
Authors: Kha Le, Man-Fung Yuen, Edward J. Gane, Kosh Agarwal, Jinlin Hou, Junqi Niu, Yanhua Ding, Xieer Liang, Alina Jucov, Min Wu, Maida Maderazo, Lawrence Blatt, Tse-I Lin, Matt McClure, Sushmita Chanda
Journal: Journal of Hepatology (2024)
THU-399-YI Burden of extrahepatic manifestations after HCV cure: assessing the effect of IFN versus DAA-induced SVR in a large population-based cohort in British Columbia, Canada
Authors: Dahn Jeong, Stanley Wong, Jean Damascene Makuza, Héctor Alexander Velásquez García, Mel Krajden, Richard Morrow, Prince Adu, Sofia Bartlett, Georgine Cua, Amanda Yu, Maria Alvarez, Naveed Janjua
Journal: Journal of Hepatology (2024)
FRI-375 The coinfection of hepatitis C virus or human immunodeficiency virus in chronic hepatitis B in South Korea: A population-based study using the Korean Health Insurance Review and Assessment Service database
Authors: Jae Yoon Jeong, Won Sohn, Hyunwoo Oh, Hyo Young Lee, Yeonjae Kim, Seong Woo Nam
Journal: Journal of Hepatology (2024)
WED-363 Promising preliminary data on preclinical efficacy with an innovative plasmid-launched live attenuated virus vaccine for chronic hepatitis B
Authors: Frederik Pauwels, Goele Bosmans, Sarah Provost, Thomas Vercruysse, Joeri Auwerx, Gregory Fanning, Mathieu Peeters, Wilfried Dalemans, Hanne Callewaert
Journal: Journal of Hepatology (2024)
WED-403 HEllenic multicenter ReAl-life CLInical Study for bulevirtide therapy in chronic hepatitis D (HERACLIS_BLV_D)
Authors: Margarita Papatheodoridi, Vasilios Sevastianos, Kalliopi Zachou, Dimitrios Christodoulou, Ioannis Koskinas, Melanie Deutsch, Alexandra Alexopoulou, Ioannis Elefsiniotis, Christos Triantos, Eleni Gigi, Theodoros Androutsakos, Dimitrios Karagiannakis, Iliana Mani, Dimitrios Dimitroulopoulos, Maria Mela, Emmanouil Sinakos, Spyridon Michopoulos, Konstantinos Mimidis, Nikolaos Papadopoulos, Athanasios Kontos, Christos Veteranos, Dimitrios Lymberopoulos, George Giannoulis, Vasilios Papadimitropoulos, Evdoxia Avramopoulou, Spyridon Pantzios, Larisa Vasilieva, Hariklia Kranidioti, Emmanouil Koullias, Nikolaos Psychos, Paraskevi Fytili, Ioannis Vlachogiannakos, Evangelos Cholongitas, Spilios Manolakopoulos, Ioannis Goulis, George Dalekos, George Papatheodoridis
Journal: Journal of Hepatology (2024)
WED-389 Pharmacokinetics and safety of the monoclonal antibody tobevibart (VIR-3434) administered as monotherapy or in combination with the small interfering RNA elebsiran (VIR-2218) in cirrhotic participants with mild hepatic impairment
Authors: Li Wang, Sneha Gupta, Michael A. Chattergoon, Asma El-zailik, Cheng Huang, George Hristopoulos, Maribel Reyes
Journal: Journal of Hepatology (2024)
WED-383 Antiviral efficacy of REP 2139-Mg and effects on HVPG in HDV/HBV coinfected patients with cirrhosis and portal hypertension nonresponding to previous bulevirtide treatment
Authors: Mathias Jachs, Michael Schwarz, Michel Bazinet, Mattias Mandorfer, Thomas Reiberger, Andrew Vaillant
Journal: Journal of Hepatology (2024)
WED-407 Characterization of hepatitis D virus RNA and hepatitis B surface antigen kinetics during pegylated interferon-alphamonotherapy: The D-LIVR study
Authors: Leeor Hershkovich, Harel Dahari, Scott Cotler, Ingrid Choong, Colin Hislop, Theo Heller, Christopher Koh, Jeffrey Glenn, Tarik Asselah, Saeed Sadiq Hamid, Ohad Etzion
Journal: Journal of Hepatology (2024)
FRI-388 Clinically significant liver stiffness decrease, as defined by the Baveno VII consensus, is associated with improved long-term prognosis in chronic hepatitis B patients with compensated advanced chronic liver disease
Authors: Rex Wan-Hin Hui, Lung Yi Loey Mak, Trevor Kwan-Hung Wu, James Fung, Man-Fung Yuen, Wai-Kay Seto
Journal: Journal of Hepatology (2024)
WED-397 Tenofovir-based antiviral therapy reduces long-term incidence of hepatocellular carcinoma in chronic hepatitis B patients
Authors: W. Ray Kim, Young-Suk Lim, Harry L.A. Janssen, Sang Hoon Ahn, Ira Jacobson, Masashi Mizokami, Grace Wong, Frida Abramov, Leland J. Yee, Hongyuan Wang, Catherine Frenette, John F. Flaherty, Scott K. Fung, Patrick Marcellin, Wai-Kay Seto, Kosh Agarwal, Jinlin Hou, Seng Gee Lim, Jia-Horng Kao, Maria Buti
Journal: Journal of Hepatology (2024)
FRI-423 Early treatment of patients with indeterminate HBV viraemia does not improve retention in care and risks overtreating patients who may spontaneously clear HBsAg
Authors: Sharon Macleod, Fiona Marra, Alison Boyle, Erica Peters, Rachael Swann, Ewan H. Forrest, Stephen Barclay
Journal: Journal of Hepatology (2024)
FRI-426 Comparing the impact of Interferon-based and direct-acting agents therapies on HBsAg seroclearance rates in patients with hepatitis B and hepatitis co-infection
Authors: Cheng Er Hsu, Yen-Chun Liu, RachelWen-Juei Jeng, Ya-Ting Cheng, Yi-Chung Hsieh, Wei Teng, Rong-Nan Chien, I-Shyan Sheen, Chun-yen Lin
Journal: Journal of Hepatology (2024)
WED-283 The distribution of fibrosis-4 index and vibration-controlled transient elastography-derived liver stiffness measurement for patients with metabolic dysfunction associated steatotic liver disease in the general population
Authors: Yuji Ogawa, Wataru Tomeno, Imamura Yasushi, Masaru Baba, Takato Ueno, Takashi Kobayashi, Michihiro Iwaki, Asako Nogami, Takaomi Kessoku, Yasushi Honda, Kento Imajo, Miwa Kawanaka, Mitsurou Hisatomi, Mamiko Takeuchi, Takashi Honda, Miwa Tatsuta, Asahiro Morishita, Shigeru Mikami, Ken Furuya, Noriaki Manabe, Tomoari Kamada, Takumi Kawaguchi, Masato Yoneda, Satoru Saito, Atsushi Nakajima
Journal: Journal of Hepatology (2024)
WED-263 A machine learning approach to identify patient features associated with metabolic dysfunction-associated steatohepatitis from the United Kingdom biobank
Authors: Jörn M Schattenberg, Amalia Gastaldelli, Harmeet Malhi, Alina M Allen, Mazen Noureddin, Umesh Karamchandani, Jonathon Romero, Peter Henstock, Birol Emir, Arun J Sanyal
Journal: Journal of Hepatology (2024)
SAT-220-YI Efruxifermin treatment improved collagen biomarkers consistent with remodelling of the extracellular matrix in patients with F2-F3 fibrosis due to MASH
Authors: Erik Tillman, Doreen Chan, Reshma Shringarpure, Diana Leeming, Morten Karsdal, Stephen A. Harrison, Andrew Cheng, Kitty Yale, Tim Rolph
Journal: Journal of Hepatology (2024)
FRI-294 Identification of key predictors of significant weight loss in metabolic dysfunction-associated steatotic liver disease (MASLD) patients: a multicentre study
Authors: Ivan Arcari, Nicola Pugliese, Simone Rocchetto, Rosa Lombardi, Grazia Pennisi, Michele Sagasta, Matteo Soleri, Federica Cerini, Annalisa Cespiati, Stella De Nicola, Francesca Colapietro, Chiara Masetti, Anna Fracanzani, Salvatore Petta, Mauro Viganò, Alessio Aghemo
Journal: Journal of Hepatology (2024)
THU-283 Characterisation of peptidylprolyl isomerase C as a novel player in the pathogenesis of chronic liver disease
Authors: Isabel Fuster-Martínez, Ana Benedicto, Cristina Benavides, José Català-Senent, Marta Hidalgo, Francisco García-García, Joan Tosca, Cristina Montón, Juan V. Esplugues, Nadezda Apostolova, Ana Blas-Garcia
Journal: Journal of Hepatology (2024)
SAT-195 Effects of icosabutate, a dual free fatty acid receptor-1 and -4 agonist, on elevated non-invasive markers of liver injury, fibrosis and glycemic control in type 2 diabetic MASH patients and F1-F3 fibrosis
Authors: Naim Alkhouri, David A. Fraser, Hilde Steineger, Mazen Noureddin, Quentin M. Anstee, Stephen A. Harrison
Journal: Journal of Hepatology (2024)
FRI-291 Stigma in steatotic liver disease (SLD): a survey of patients from Saudi Arabia
Authors: Saleh Alqahtani, Khalid A. Alswat, Mohammad Mawardi, Faisal Sanai, Faisal Aba Alkhail, Saad Alghamdi, Waleed K. Al-Hamoudi, Fatema Nader, Maria Stepanova, Zobair Younossi
Journal: Journal of Hepatology (2024)
WED-327 Utility of transient elastography in inflammatory bowel disease
Authors: Arun Vaidya, Vaibhav Padole, Chetan Saner, Jitendra Yadav, Shubham Gupta, Ankita Singh, Sidharth Harindranath, Biswa Ranjan Patra, Leela Shinde, Apurva Kubal, Mayur Satai, Love Garg, Michael Kuruthukulangara, Nitish Patwardhan, Akash Shukla
Journal: Journal of Hepatology (2024)
WED-272 A self-testing index for detecting hepatic steatosis and prognostication in the general population
Authors: Chuan Liu, Shanghao Liu, Jie Shen, Jie Li, Jingli Gao, Heng Wan, Qun Zhang, Donghan Su, Hao Liu, Yi Dong, Jia Li, Lan Liu, Shan Wang, Guangjian Li, Yiling Li, Yu Jun Wong, Qing-Lei Zeng, Zhihui Li, Shenghong Ju, Wenhong Zhang, Michael Pavlides, Vincent Wai-Sun Wong, Gao-Jun Teng, Xiaolong Qi
Journal: Journal of Hepatology (2024)
WED-245 Should specific cutoffs be used for diagnosing fibrotic MASH in patients with type 2 diabetes using FAST, MAST, MEFIB and FNI?
Authors: Laurent Castera, Philippe Garteiser, Cedric Laouenan, Tiphaine Vidal-Trecan, Anais Vallet Pichard, Pauline Manchon, Valérie Paradis, Sebastien Czernichow, Dominique Roulot, Etienne Larger, Stanislas Pol, Pierre Bedossa, Correas Jean Michel, Dominique Valla, Jean-François Gautier, Bernard van Beers
Journal: Journal of Hepatology (2024)
WED-255-YI Muscle composition as a predictor of advanced fibrosis in chronic liver disease
Authors: Wile Balkhed, Patrik Nasr, Mikael Forsgren, Anna Cederborg, Olof Dahlqvist Leinhard, Simone Ignatova, Peter Lundberg, Nils Dahlström, Christian Simonsson, Stergios Kechagias, Mattias Ekstedt
Journal: Journal of Hepatology (2024)
WED-215 HeparDx™ (by Metadeq, Inc.) is a reliable biomarker-based non-invasive test for MASH, capable of detecting the presence of inflammation and ballooning
Authors: Giulia Angelini, Sara Russo, Erminia Lembo, Ornella Verrastro, Caterina Guidone, Antonio Liguori, Stephen A. Harrison, Aldo Trylesinski, Luca Miele, Geltrude Mingrone
Journal: Journal of Hepatology (2024)
WED-320 Optimizing non-alcoholic fatty liver disease care using mac-2 binding protein glycosylation isomer and correlations with advanced diagnostics
Authors: Thu Thuy Pham Thi, Dat Ho Tan, Chanh Pham Cong, Boi Hoan Phan Huu, Thai Bieu Phu Dung, Toan Nguyen Bao, Khue Nguyen Minh
Journal: Journal of Hepatology (2024)
THU-297 Treatment with the CCR2/CCR5 antagonist Cenicriviroc does not affect MASH and fibrosis development in Ldlr-/-.Leiden mice, translational to clinical phase 3 trial results
Authors: Martine C. Morrison, Eveline Gart, Wim van Duyvenvoorde, Jessica Snabel, Aswin L. Menke, Anita M. van den Hoek, Robert Kleemann
Journal: Journal of Hepatology (2024)
THU-249 The role of the ferroptosis brake glutathione peroxidase 4 in a preclinical model of metabolic dysfunction-associated steatohepatitis
Authors: Cédric Peleman, Geraldine Veeckmans, Behrouz Hassannia, Lieve Vits, Emily Van San, Joris De Man, Annelies Van Eyck, Wilhelmus J. Kwanten, Luisa Vonghia, Ann Driessen, Benedicte De Winter, Christophe Van Steenkiste, Sven Francque, Tom Vanden Berghe
Journal: Journal of Hepatology (2024)